Illumina | ILMN - Current Liabilities

Stock Price
127.88
Daily Change
2.44 1.95%
Monthly
1.33%
Yearly
65.33%
Q2 Forecast
125.14

Illumina reported $1.59B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.34B 62M Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Quidel USD 966.1M 198.2M Dec/2025
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Standard Biotools USD 108.31M 343K Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Waters USD 1.24B 11.8M Dec/2025